300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Blockchain
Facebook
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Nigeria
Isle of Man
Pakistan
Russian Federation
Romania
Togo
Tajikistan
Zimbabwe
Oman
Cameroon
Colombia
India
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in United Kingdom (June 2026)

The most active venture capital funds investing in United Kingdom Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
UK Innovation & Science Seed Fund
VC Fund
57 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $393k–$14M
Parkwalk Advisors
VC Fund
44 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $982k–$46M
Scottish Enterprise
VC Fund
43 United Kingdom, United States, Japan Grant, Seed Biotechnology, Software, Health Care $104k–$4.8M
Oxford Science Enterprises
VC Fund
41 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
SOSV
VC Fund
37 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Oxford Technology Management
VC Fund
34 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $33k–$7.9M
Catapult Ventures
VC Fund
29 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Medical $150k–$26M
Scottish Investment Bank
VC Fund
28 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Health Care $327k–$7M
Mercia Fund Managers
VC Fund
26 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $196k–$14M
Development Bank of Wales
VC Fund
24 United Kingdom, Australia, United States Seed, Debt Financing Software, Health Care, Biotechnology $18k–$3.7M
Sofinnova Partners
VC Fund
23 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$120M
Epidarex Capital
VC Fund
23 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $531k–$55M
SFC Capital
VC Fund
23 United Kingdom, United States, Canada Pre-Seed, Seed Software, Artificial Intelligence, Information Technology $162k–$2.2M
Archangels
VC Fund
22 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $1.3M–$8.3M
IP Group
VC Fund
22 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $393k–$23M
Oxford Capital
VC Fund
21 United Kingdom, United States, France Seed, Series A Software, Health Care, Mobile $1.5M–$16M
AlbionVC
VC Fund
21 United Kingdom, United States, France Series A, Seed Software, Information Technology, Health Care $2.2M–$20M
Future Planet Capital
VC Fund
21 United Kingdom, United States, Spain Seed, Convertible Note Biotechnology, Health Care, Software $897k–$7.9M
Northstar Ventures
VC Fund
19 United Kingdom, United States, Indonesia Seed, Series A Software, Health Care, E-Commerce $39k–$9.7M
Deepbridge Capital
VC Fund
19 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $152k–$15M
Wren Capital
VC Fund
18 United Kingdom Seed, Series A Biotechnology, Health Care, Medical $1.1M–$32M
Octopus Ventures
VC Fund
18 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, Information Technology $1.9M–$48M
GM&C Life Sciences Fund
VC Fund
18 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $65k–$4.1M
O2h Ventures
VC Fund
17 United Kingdom, Hungary Seed, Series A Biotechnology, Health Care, Pharmaceutical $655k–$26M
Cambridge Innovation Capital
VC Fund
17 United Kingdom, United States, Ireland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$73M
Syncona Partners LLP
VC Fund
16 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.8M–$131M
TRICAPITAL
VC Fund
16 United Kingdom, France Seed, Series B Biotechnology, Software, Health Care
Kelvin Capital
VC Fund
16 United Kingdom, United States Seed, Series A Health Care, Biotechnology, Manufacturing $144k–$25M
Eos
VC Fund
15 United Kingdom, Ireland, United States Seed, Series A Biotechnology, Health Care, Medical $1.3M–$47M
IQ Capital
VC Fund
15 United Kingdom, United States, Germany Seed, Series A Software, Artificial Intelligence, Machine Learning $1.3M–$44M
Hoxton Ventures
VC Fund
15 United Kingdom, United States, Canada Seed, Series A Artificial Intelligence, Software, Health Care $1.8M–$29M
Kindred Capital
VC Fund
14 United Kingdom, United States, Germany Seed, Series A, Series B Software, Biotechnology, Health Care $1.5M–$73M
Calculus Capital
VC Fund
14 United Kingdom, United States, Ireland Series A, Seed Biotechnology, Software, Medical $2M–$18M
M Ventures
VC Fund
14 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Newable Private Investing
VC Fund
14 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $196k–$5.2M
Par Equity
VC Fund
14 United Kingdom, United States, Brazil Series A, Seed Software, Information Technology, Health Care $380k–$14M
Business Growth Fund
VC Fund
14 United Kingdom, Ireland, United States Series A, Private Equity Software, Health Care, Information Technology $3.2M–$22M
Nesta Ventures
VC Fund
13 United Kingdom, United States Seed, Series A Biotechnology, Medical Device, Medical $982k–$26M
Cambridge Angels group
VC Fund
13 United Kingdom, United States, Estonia Seed, Series A Software, Health Care, Biotechnology $270k–$9.5M
SR One
VC Fund
13 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$150M
Clarendon Fund Managers
VC Fund
12 United Kingdom, United States, Ireland Seed, Pre-Seed Software, Health Care, Biotechnology $440k–$2.6M
Longwall Venture
VC Fund
12 United Kingdom, Germany, Philippines Seed, Series A Biotechnology, Health Care, Medical Device $637k–$16M
Maven Capital Partners
VC Fund
12 United Kingdom, United States, Germany Seed, Series A Software, Information Technology, SaaS $655k–$25M
Wellcome Trust
VC Fund
12 United States, United Kingdom, France Grant, Series C Biotechnology, Health Care, Medical $1.3M–$127M
F-Prime
VC Fund
12 United States, United Kingdom, China Series A, Series B, Series C Health Care, Biotechnology, Medical $9.2M–$130M
YFM Equity Partners
VC Fund
12 United Kingdom, United States, Belgium Private Equity, Series A Software, Information Technology, Biotechnology $2.6M–$10M
Mercia Asset Management
VC Fund
11 United Kingdom, United States Series A, Seed Software, Information Technology, Health Care $524k–$13M
Amadeus Capital Partners
VC Fund
11 United Kingdom, United States, Spain Series B, Seed, Series A Software, Artificial Intelligence, Information Technology $900k–$43M
SIS Ventures
VC Fund
11 United Kingdom Seed, Series A Biotechnology, Health Care, Medical $1M–$19M
BACKED VC
VC Fund
11 United Kingdom, United States, France Seed, Series A Software, Blockchain, Biotechnology $2M–$58M
Access all 1755 VC funds in United Kingdom Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 57 investments in United Kingdom Biotech startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 131
  • Round size: Seed $393k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • HonuWorx — HonuWorx is a subsea robotics company founded with a mission to replace surface vessels with underwater deployment platforms.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Aquark Technologies — Aquark Technologies develops atom systems to develop quantum applications, including atomic clocks, sensors, and navigation systems. Aquark develops a technique to miniaturize cold atom systems using unique laser geometry that is based on more than 10 years of proprietary research at the University of Southampton.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 44 investments in United Kingdom Biotech startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 259
  • Round size: Seed $982k–$5M; Series A $1.6M–$13M; Series B $2M–$46M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
  • Bramble Energy — Bramble Energy is an innovator energy technology company that designs and manufactures high-performance, low-cost, and fuel cell stack. The company ability to leverage the global high-volume PCB industry means that they are the first fuel cell company with the manufacturing capacity to supply gigawatts of fuel cell hardware, something the batteryindustry has spent many years and £B’s to achieve.Bramble Energy specifically uses a printed circuit board (PCB) technology to form the structural parts of the fuel cell. It also provides products including modular PCBFC stacks, H20:20W PCBFC system, custom design PCBFC, and 500W PCBFC stack.Bramble Energy was founded in 2016 and is based in London, England, United Kingdom.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 43 investments in United Kingdom Biotech startups

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 313
  • Round size: Seed $318k–$3.8M; Grant $104k–$4.8M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Gigged.AI — Fill skill gaps using our on-demand talent network. Get AI-powered, real-time visibility over your employee and agent capabilities to power internal mobility.
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
  • Smart Green Shipping — smart green shipping alliance. economically, socially and environmentally superior shipping solutions.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 41 investments in United Kingdom Biotech startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 166
  • Round size: Seed $1.3M–$12M; Series A $5M–$46M; Series B $8.5M–$168M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $327M in 2022

Portfolio highlights

  • Pepgen — PepGen empowers nucleic acid therapeutics to go the distance. PepGen's ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of their innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides,and they are advancing novel conjugate therapeutics to the clinic.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 37 investments in United Kingdom Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 34 investments in United Kingdom Biotech startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 107
  • Round size: Seed $33k–$2.1M; Series A $786k–$7.9M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 29 investments in United Kingdom Biotech startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 104
  • Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Rinicare — Rinicare is Lancaster-based SME that offers innovative technology solutions for healthcare applications.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 28 investments in United Kingdom Biotech startups

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 208
  • Round size: Seed $327k–$3.1M; Series A $1.6M–$7M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 26 investments in United Kingdom Biotech startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 135
  • Round size: Seed $196k–$2M; Series A $2M–$14M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Sen — Sen's vision is to democratize space using video to inform, educate, inspire and benefit all humanity. Sen's mission is to stream real-time videos from space to billions of people, gathering news and information about Earth and space and making it universally accessible.
  • 4D Medicine
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 24 investments in United Kingdom Biotech startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 221
  • Round size: Seed $327k–$3.7M; Debt Financing $18k–$3.7M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2018

Portfolio highlights

  • Tourhub — tourhub - We collect tours from hundreds of suppliers around the world and provide an easy way for you to search and find those that are of interest.
  • Antiverse — Designing biologics for 100 challenging targets
  • Hope Macy — Hope Macy is the decisioning and origination layer that modern consumer lenders build on.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 23 investments in United Kingdom Biotech startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 309
  • Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
  • l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
  • EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 23 investments in United Kingdom Biotech startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 48
  • Round size: Seed $531k–$8.5M; Series A $2.6M–$40M; Series B $2.4M–$55M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Leucid Bio — CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
  • AdoRx Therapeutics — AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. High levels of adenosine in the tumour microenvironment enable cancer to evade the immune system. AdoRx’s lead programs are focused on the design of “fit for purpose” adenosine receptor antagonists that will overcome the effectsof high adenosine levels. AdoRx Therapeutics is a UK-based drug discovery company and backed by investment from Epidarex Capital and Sixth Element Capital. The AdoRx leadership team have discovered in excess of 25 clinical candidates and have greater than 60 years combined experience of drug discovery in biotech and pharma.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

SFC Capital
VC Fund · London, England, United Kingdom · 23 investments in United Kingdom Biotech startups

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 378
  • Round size: Seed $164k–$2.2M; Pre-Seed $162k–$840k
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Elaitra — Elaitra’s breast cancer platform includes a Generative LLM for voice-based patient engagement, and a unique AI reading tool that helps doctors read 3D X-Rays. Operating in USA & UK. FDA 510(k) and UK regulator approved.
  • Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
  • WeFindFlats — Live and work anywhere, without housing worries.
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 22 investments in United Kingdom Biotech startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 22 investments in United Kingdom Biotech startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 191
  • Round size: Seed $393k–$7.6M; Series A $2M–$23M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2014

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 21 investments in United Kingdom Biotech startups

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Health Care, Mobile
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 147
  • Round size: Seed $1.5M–$3.9M; Series A $3.2M–$16M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $56M in 2015

Portfolio highlights

  • eporta — eporta is Europe's leading B2B commerce platform for the furnishings industry, active in over 80 countries around the world.
  • UltraSoC Technologies — UltraSoC Technologies is an independent provider of SoC infrastructure to enable rapid development of embedded systems based on advanced SoC devices. Its head office is in Cambridge and it has research and development labs in Colchester.
  • Intent HQ — Intent builds AI that understands human intent. On-device processing. Zero personal data exported. 300M+ profiles. 49 patents.
Show all investments...

AlbionVC
VC Fund · London, England, United Kingdom · 21 investments in United Kingdom Biotech startups

AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 164
  • Round size: Seed $2.2M–$13M; Series A $3.8M–$20M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Runa — Businesses from every walk of life use rewards to acquire, retain and thank customers but the current process is broken. Sending rewards, incentives and non-cash payouts is manual, expensive, time-consuming and error-prone. WeGift changes this. Operating in more than 30 countries, in 22 languages, 20 currencies, with over 700 brand partners, andhundreds of clients, like Perkbox, Sodexo, New Look and Halfords among others, WeGift’s cloud-based, open API solutions allow businesses to transfer value to consumers, in real-time and globally. Established in 2016, WeGift is backed by leading entrepreneurs and investors.
  • Hussle — Gym membership with total flexibility. Gym passes to no contract gym memberships that you can use in thousands of gyms across the UK. Gym and swim wherever you want to. Stop and start whenever you like.
  • Clear Review — Enable conversations to drive meaningful relationships and ensure employees feel supported to reach their goals, so organisations can achieve what matters most.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 21 investments in United Kingdom Biotech startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 145
  • Round size: Seed $897k–$7.9M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Rovco — Rovco designs an autonomous underwater vehicle or AUV and remotely operated underwater vehicle or ROV technologies and support services that optimizes how people manage and inspect subsea assets. Its technology offers the process of 3D photogrammetry that involves using high-resolution photos of a static object or site area taken from multipleangles and processed to generate a 3D vector model from point cloud data, enabling oil, gas, and renewables industry clients to evaluate their subsea assets for damage, corrosion or determining levels of marine growth and benefit from inspection related cost savings.
  • Aloqia — Take control of your excess inventory with Aloqia. Resell, reuse, recycle, and prevent surplus while driving sustainability and supply chain resilience.
  • Captura — Captura is harnessing the power of the ocean to heal the climate through Direct Ocean Capture technology.
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 19 investments in United Kingdom Biotech startups

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 190
  • Round size: Seed $39k–$1.8M; Series A $851k–$9.7M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
  • CellRev — high expertise in the designing and testing of self-assembling peptides providing different benefits when culturing adherent cells in vitro.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 19 investments in United Kingdom Biotech startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 84
  • Round size: Seed $152k–$2.6M; Series A $2M–$15M
  • Lead/follow: 74% lead, 26% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • HeadBox — HeadBox connects corporate event planners with 100,000+ unique, inspiring, iconic, and creative spaces worldwide for meetings and events.
  • Touch Biometrix — Welcome at Touch Biometrix. Find out more about The Future of Fingerprint Biometrics!
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wren Capital
VC Fund · London, England, United Kingdom · 18 investments in United Kingdom Biotech startups

Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 33
  • Round size: Seed $1.1M–$5.2M; Series A $2M–$32M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
  • SenseAI
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 18 investments in United Kingdom Biotech startups

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 369
  • Round size: Seed $1.9M–$13M; Series A $3M–$21M; Series B $7.5M–$48M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — raised $101M in 2019

Portfolio highlights

  • Wazoku — Wazoku - Where Innovation Works Wazoku
  • CertiVox — CertiVox solutions deliver simple, powerful information security to all things Internet (mainframes, too!), protecting business and individual privacy through the cloud and at rest. CertiVox was founded in 2009 to provide technology and services based on a simple belief: that everyone deserves the right to secure their information exchangessimply and easily. CertiVox's leading-edge encryption, key management and identity management solutions are currently in use at hundreds of the world’s leading corporations and used by individuals across the globe to protect their privacy.The companies passion is to create and share unique, cutting-edge cryptographic innovations for enterprise cloud computing and all things Internet. CertiVox are the only company in the global market today that has the technology in place to arm businesses and individuals with easy-to-use certificateless security solutions for any device and platform.Whether you are a business that wants to safeguard your company’s intellectual property, an ISV or SaaS provider that needs to embed cryptography and key management into your application, or an individual who wants to preserve the privacy of your personal data, CertiVox gives you the power to secure your information for all things Internet.CertiVox’s leading-edge solutions – including MIRACL (Multiprecision Integer and Rational Arithmetic C/C++ Library) Cryptographic SDK, on-demand encryption Key Management Service (KMS) and Identity Management Service (IDMS) – enable cloud service providers, independent software vendors (ISVs), communication providers, and smart device and semiconductor manufacturers to secure their voice and data communication solutions with ease.The PrivateSky Secure Information Exchange Service (SIX) gives individuals, businesses and their partners and customers easy-to-use tools to quickly encrypt email, files and documents without complex infrastructure or user burden. Compliance with mandatory encryption and privacy statues has never been easier.The bottom line: CertiVox's revolutionary certificateless cryptography, identity and key management solutions have taken the hassle out of Internet security, making it easy to securely exchange your information in any form, any time.
  • Mojo — Join 600,000+ men worldwide using AI-powered coaches to build a performance mindset and take back control of their love lives.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 18 investments in United Kingdom Biotech startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 33
  • Round size: Seed $65k–$936k; Series A $1.8M–$4.1M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
  • Acea Health — Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .
  • Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Show all investments...

O2h Ventures
VC Fund · 17 investments in United Kingdom Biotech startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 39
  • Round size: Seed $655k–$7.9M; Series A $1.9M–$26M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Neurocentrx — Neurocentrx is a specialty pharma company, developing and in-licensing products in pain, palliative care, psychiatry and mood disorders.
  • Alevin Therapeutics — Our mission is to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 17 investments in United Kingdom Biotech startups

As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 97
  • Round size: Seed $3.9M–$23M; Series A $2M–$73M; Series B $8.5M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
  • Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
  • Forefront RF — Forefront RF tunable duplexer technology expands the accessibility of all mobile devices by unlocking SDR capabilities in the RFFE front end.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 16 investments in United Kingdom Biotech startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 52
  • Round size: Seed $1.8M–$17M; Series A $17M–$110M; Series B $24M–$131M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quell Therapeutics — Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions. Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

TRICAPITAL
VC Fund · Melrose, Scottish Borders, The, United Kingdom · 16 investments in United Kingdom Biotech startups

The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series B
  • Geography: United Kingdom, France

Investor stats

  • Total investments: 49
  • Lead/follow: no public data

Portfolio highlights

  • HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
  • Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
  • Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
Show all investments...

Kelvin Capital
VC Fund · Glasgow, Glasgow City, United Kingdom · 16 investments in United Kingdom Biotech startups

Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 79
  • Round size: Seed $144k–$1.3M; Series A $1.7M–$25M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
  • Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Show all investments...

Eos
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 15 investments in United Kingdom Biotech startups

Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 40
  • Round size: Seed $1.3M–$6.1M; Series A $1.6M–$47M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Neupulse — We are developing a wearable wrist device that delivers median nerve stimulation at the press of a button with the aim to give people control of their tics.
  • Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
  • Nami Surgical — Nami Surgical provides robotic surgery technology solutions to enhance patient care while giving surgeons intuitive, high-performance moveable instruments.
Show all investments...

IQ Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 15 investments in United Kingdom Biotech startups

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 190
  • Round size: Seed $1.3M–$13M; Series A $4.5M–$44M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Molyon — Molyon is creating the next-generation energy storage system: the lithium-sulfer battery. Molyon offers long-life lithium-sulfur batteries that have twice the energy density of existing lithium-ion batteries on the market.
  • Nyobolt — Nyobolt develops high-power energy storage systems based on advanced lithium-ion battery technology designed for rapid charging and sustained high performance. The company focuses on battery systems that enable very fast energy replenishment, supporting applications where downtime needs to be minimized. Its technology combines specialized anodematerials, cell design, battery management systems, and power electronics to achieve high charge and discharge rates. The platform is used in sectors such as robotics, data centers, industrial equipment, and electric mobility where consistent high power delivery is required. It also develops integrated energy solutions that support demanding workloads like automated logistics systems and high-performance computing infrastructure. Nyobolt’s approach emphasizes optimizing cycle life, thermal stability, and energy density for repeated fast charging environments.
  • Nu Quantum — Nu Quantum has been pioneering quantum networking technology since 2018. Our market-leading expertise is uniquely positioned to deliver a distributed quantum...
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Hoxton Ventures
VC Fund · London, England, United Kingdom · 15 investments in United Kingdom Biotech startups

Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 129
  • Round size: Seed $1.8M–$12M; Series A $5M–$29M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
  • Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
  • Peptone — We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 14 investments in United Kingdom Biotech startups

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 112
  • Round size: Seed $1.5M–$16M; Series A $7.9M–$33M; Series B $13M–$73M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Paddle — The revenue engine powering payments for n8n, Letterboxd & AdGuard. One platform that handles subscription billing, payments and compliance.
  • Mojo — Join 600,000+ men worldwide using AI-powered coaches to build a performance mindset and take back control of their love lives.
  • how.fm — Training software for better onboarding processes and digital store floor management. Train staff with no effort and language barriers.
Show all investments...

Calculus Capital
VC Fund · London, England, United Kingdom · 14 investments in United Kingdom Biotech startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 73
  • Round size: Seed $2M–$18M; Series A $2.6M–$9.2M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Optalitix — Optalitix's data driven products and expertise allow you to move your models to the cloud and improve underwriting efficiency.
  • Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
  • Rotageek — Rotageek helps organisations predict and meet demand, using complex data-driven technologies to effectively and fairly schedule staff. They use personalised algorithms and machine learning to find patterns that would otherwise go unnoticed - providing best in class and fully personalised business forecasting and scheduling. Today, Rotageek livesin London and Melbourne and their clients include O2, Dune, William Hill, Maplin and The Perfume Shop to name just a few. They’re growing really quickly but their approach and their ambitions remain personal, and they always will. Their goal is to create a step change in scheduling capabilities using data-driven, highly intelligent technology that is agile and works both for business and people.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 14 investments in United Kingdom Biotech startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 170
  • Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Biolinq — Introducing a revolutionary platform for metabolic health.
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 14 investments in United Kingdom Biotech startups

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 103
  • Round size: Seed $196k–$3.9M; Series A $1.3M–$5.2M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Elemendar — Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information.
  • NuVision — NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham.
Show all investments...

Par Equity
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 14 investments in United Kingdom Biotech startups

Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Brazil

Investor stats

  • Total investments: 194
  • Round size: Seed $380k–$8M; Series A $1.7M–$14M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Verlume — Subsea energy storage and remote power generation for the energy transition, low carbon offshore operations and zero emission hydrocarbon production.
  • Cyan Forensics — Cyan Forensics builds and sells new technologies to help law enforcement, social media companies, and cloud providers to find and block harmful content from paedophiles and terrorists.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
Show all investments...

Business Growth Fund
VC Fund · London, England, United Kingdom · 14 investments in United Kingdom Biotech startups

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Private Equity
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 309
  • Round size: Series A $3.2M–$21M; Private Equity $6.5M–$22M
  • Lead/follow: 83% lead, 17% follow
  • Last fund: Likely still investing — raised $102M in 2022

Portfolio highlights

  • Origin Tech — Origin Tech is a UK-based water technology company that has won numerous awards. Our commitment is to minimize water waste and maintain the integrity of water supply systems globally.
  • CHS Healthcare — CHS Healthcare Has Been Working In Partnership With The NHS For 20 Years, Providing Specialist Support Schemes Across The UK. Get In Touch Today.
  • Evolution Aqua — Evolution Aqua is a designer, manufacturer and supplier of a wide range of water filtration products and associated equipment, primarily focused on the aquatics industry for both indoor and outdoor fish care.
Show all investments...

Nesta Ventures
VC Fund · London, England, United Kingdom · 13 investments in United Kingdom Biotech startups

We bring bold ideas to life to change the world for good.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $982k–$2.2M; Series A $1.5M–$26M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2014

Portfolio highlights

  • Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
  • Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
  • Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
Show all investments...

Cambridge Angels group
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 13 investments in United Kingdom Biotech startups

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 131
  • Round size: Seed $270k–$2.9M; Series A $2M–$9.5M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • MNS
  • FLIT — Unfold Your Next Adventure. Discover the compact folding electric bike purpose-built for commuters, urban explorers and weekend tourers.
  • AVIEL Intelligence — Prevent APP fraud with the highest quality of intelligence. Use AVIEL intelligence to help prevent your customers making payments to scammers - and from receiving payments related to scams.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 13 investments in United Kingdom Biotech startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 189
  • Round size: Series A $3.7M–$140M; Series B $15M–$114M; Series C $22M–$150M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Turning Point Therapeutics — The Investor Relations website contains information about Turning Point Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
  • River Vision Development — River Vision Development develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). River Vision Development was founded in 2011 and is based in New York, New York.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Clarendon Fund Managers
VC Fund · Belfast, Belfast, United Kingdom · 12 investments in United Kingdom Biotech startups

We ensure that businesses in Northern Ireland with growth aspirations can access equity finance to reach their potential.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 68
  • Round size: Seed $440k–$2.6M; Pre-Seed $735k–$1.5M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $17M in 2003

Portfolio highlights

  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • TeamFeePay — TeamFeePay is a software company for football club management.
Show all investments...

Longwall Venture
VC Fund · Harwell, Oxfordshire, United Kingdom · 12 investments in United Kingdom Biotech startups

Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Seed, Series A
  • Geography: United Kingdom, Germany, Philippines

Investor stats

  • Total investments: 46
  • Round size: Seed $637k–$5.6M; Series A $2.4M–$16M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $101M in 2017

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • Kinomica — Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Maven Capital Partners
VC Fund · Glasgow, Glasgow City, United Kingdom · 12 investments in United Kingdom Biotech startups

Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 194
  • Round size: Seed $655k–$5.2M; Series A $2.6M–$25M
  • Lead/follow: 74% lead, 26% follow

Portfolio highlights

  • Near-Life — The simplest, fastest platform for learning teams to create high quality interactive video and VR simulations
  • Novatus Advisory — Novatus Advisory - Successfully guiding enterprises through the ever-changing Risk and Regulation Landscape
  • Chorus Intelligence — Trusted suppliers of digital investigation software that enables our customers to confidently turn data into intelligence and evidence.
Show all investments...

Wellcome Trust
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups, 8 in the past 12 months

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 121
  • Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $319M in 2018

Portfolio highlights

  • System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
  • Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
  • Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Show all investments...

F-Prime
VC Fund · Cambridge, Massachusetts, United States · 12 investments in United Kingdom Biotech startups

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 423
  • Round size: Series A $9.2M–$87M; Series B $16M–$130M; Series C $22M–$115M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Axle Health — Axle Health provides scheduling and workforce management software to help home healthcare and hospice providers improve their clinician productivity.
  • CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
  • RightHand Robotics — RightHand Robotics offers advanced robotic piece-picking technology for efficient and predictable order fulfillment. Contact us today to learn how.
Show all investments...

YFM Equity Partners
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups

YFM Equity Partners is an independent private equity business owned by its senior management and investment team. They invest up to £10 million of equity through offices in Leeds, London, Manchester, Birmingham and Sheffield.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Private Equity, Series A
  • Geography: United Kingdom, United States, Belgium

Investor stats

  • Total investments: 122
  • Round size: Series A $4.7M–$10M; Private Equity $2.6M–$10M
  • Lead/follow: 76% lead, 24% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Vuealta — Vuealta Consulting helps businesses grow and prepare for the unexpected. Learn more about the software solutions Vuealta can offer businesses across the globe
  • DynaRisk — DynaRisk is a cyber security company. DynaRisk combines personal risk factors with external data and algorithms to determine an individual’s level of risk online.
  • Integrum ESG — Transparent, AI-powered ESG intelligence for institutional investors. Glass-box data, 60,000+ companies, 10-day refresh. Cut cost, eliminate black boxes.
Show all investments...

Mercia Asset Management
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 11 investments in United Kingdom Biotech startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 101
  • Round size: Seed $524k–$3.1M; Series A $2.2M–$13M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
  • Semble — The integrated clinical system for managing your patients' medical data and admin tasks.
  • Locate Bio — Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 11 investments in United Kingdom Biotech startups

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Seed, Series A
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 234
  • Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$43M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $88M in 2023

Portfolio highlights

  • Pimloc — Pimloc's deep learning platform enables private businesses and public organisations to protect sensitive or personal data in video, to maintain safe online environments and to manage video security.
  • XYZ Reality — XYZ Reality - The world's first Engineering-Grade augmented reality system for construction.
  • Altana — Altana powers trusted trade for governments and businesses worldwide. Map supply chains, manage tariffs, ensure compliance, and build resilience with AI.
Show all investments...

SIS Ventures
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 11 investments in United Kingdom Biotech startups

SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 33
  • Round size: Seed $1M–$5.2M; Series A $2.8M–$19M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $1M in 2018

Portfolio highlights

  • Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
  • MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
  • Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Show all investments...

BACKED VC
VC Fund · London, England, United Kingdom · 11 investments in United Kingdom Biotech startups

BACKED is the human-centric venture capital fund. We invest in exceptional founders, at Seed, in Europe. We provide founders with an extensive support system to catalyse their development as a company operators and leaders. Through our Founder Experience Platform and energetic portfolio community we help entrepreneurs across all areas of a startup:from talent management to business development, further fundraising and international expansion.Founded in 2015 by partners Andre de Haes and Alex Brunicki, we invest across sectors including BioTech, Entertainment, Financial Services, Industry 4.0 and more. Investments to date include Hutch, Pollen, Thought Machine, LabGenius, THIS, Enterprise Alumni, and many more.

Show more...

Investment focus

  • Industry: Software, Blockchain, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 105
  • Round size: Seed $2M–$8.7M; Series A $5.5M–$58M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $88M in 2022

Portfolio highlights

  • Flexciton — Flexciton is the ultimate scheduling optimization solution for semiconductor wafer fabs. Flexciton applies cutting-edge technology to optimize the planning and scheduling decisions for the world's most complex manufacturing process - semiconductor wafer fabrication.
  • Bird Buddy — Bird Buddy is a smart bird feeder that notifies you of feathered visitors, captures their photos and organizes them in a beautiful collection!
  • Infinity Constellation — Infinity Constellation is an AI-focused startup holding company and incubator that builds and launches service-based businesses leveraging artificial intelligence. Their mission is to empower visionary founders to create the next generation of impactful, tech-enabled companies, emphasizing long-term growth and sustainable value creation.
Show all investments...

Biotech VC funding in United Kingdom at a glance

Stats across 2.4k deals from 1.8k investors.

1.8k
investors
in United Kingdom Biotech startups
2.4k
deals
in United Kingdom Biotech startups
$3.4M
median round
in United Kingdom Biotech startups
44%
lead investors
lead at least one round
25%
Seed
most common funding stage

Access all 1755 VC funds in United Kingdom Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1755 VC funds investing in United Kingdom Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists